![]() |
Home | Forums | ![]() |
![]() |
Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer
«
Previous Thread
|
Next Thread
»
All times are GMT. The time now is 02:17 AM.
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |